| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |